Figure 4.
Comparison of endometrial thickness (mm) of Remifemin and tibolone before and after GnRH-a therapy: * p<0.05, ** p<0.01, vs. the Remifemin group before GnRH-a therapy; # p<0.05, ## p<0.01, vs. the tibolone group before GnRH-a therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.